Search research articles
Contact Us
Filters
Showing results (121-130 of 133) with videos related to
Page
of 14
Sort By:
Nature Cancer
|
September 22, 2022
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes
Satyaki Sengupta, Sanjukta Das, Angela C Crespo, et al.
Cancer Cell
|
September 23, 2022
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
Shunsuke Kitajima, Tetsuo Tani, Benjamin F Springer, et al.
The Journal of Clinical Investigation
|
November 5, 2020
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade
Kartik Sehgal, Andrew Portell, Elena V Ivanova, et al.
Nature Cancer
|
October 7, 2025
A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma
William Zhao, Thinh T Nguyen, Atharva Bhagwat, et al.
Nature Cancer
|
July 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
Ines Mota, Enrico Patrucco, Cristina Mastini, et al.
JCI Insight
|
January 23, 2026
EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy
Atsuko Ogino, Amir Vajdi, Xinmeng Jasmine Mu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 11, 2024
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, et al.
Cancer Immunology Research
|
September 8, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors
Elliott J Brea, Simon Baldacci, Neil Savage, et al.
Cancer Discovery
|
August 5, 2025
Eradicating Drug Tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T cellular therapy
Simon Baldacci, Elliott J Brea, Francesco Facchinetti, et al.
JAMA Oncology
|
June 16, 2022
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
Biagio Ricciuti, Xinan Wang, Joao V Alessi, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 133) with videos related to
Sort By:
Page
of 14
Nature Cancer
|
September 22, 2022
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes
Satyaki Sengupta, Sanjukta Das, Angela C Crespo, et al.
Cancer Cell
|
September 23, 2022
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
Shunsuke Kitajima, Tetsuo Tani, Benjamin F Springer, et al.
The Journal of Clinical Investigation
|
November 5, 2020
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade
Kartik Sehgal, Andrew Portell, Elena V Ivanova, et al.
Nature Cancer
|
October 7, 2025
A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma
William Zhao, Thinh T Nguyen, Atharva Bhagwat, et al.
Nature Cancer
|
July 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
Ines Mota, Enrico Patrucco, Cristina Mastini, et al.
JCI Insight
|
January 23, 2026
EGFR-mutant transformed small cell lung cancer harbors intratumoral heterogeneity targetable with MEK inhibitor combination therapy
Atsuko Ogino, Amir Vajdi, Xinmeng Jasmine Mu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 11, 2024
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, et al.
Cancer Immunology Research
|
September 8, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors
Elliott J Brea, Simon Baldacci, Neil Savage, et al.
Cancer Discovery
|
August 5, 2025
Eradicating Drug Tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T cellular therapy
Simon Baldacci, Elliott J Brea, Francesco Facchinetti, et al.
JAMA Oncology
|
June 16, 2022
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels
Biagio Ricciuti, Xinan Wang, Joao V Alessi, et al.
Page
of 14